Epilepsy Society's Clare Pelham discusses sodium valproate and EMA public hearing on BBC News
Watch and listen to Epilepsy Society's CEO Clare Pelham discussing our sodium valproate survey and the European Medicine's Agency public hearing into the epilepsy drug on various BBC News programmes over the last few days.
Research using Apple watch links epileptic seizures to stress and missed sleep
New research using an Apple Watch app to track seizures in people with epilepsy has found that the most common triggers are often stress and missed sleep.
Charity calls for greater public awareness as people with epilepsy are accused of being drunk following a seizure
As dry January ends, Epilepsy Society is urging the public to think twice before assuming that a person who is staggering around in a confused state, is drunk.
Warning over morning-after-pill for women with epilepsy
Women with epilepsy are being advised to consult their doctor, pharmacist or specialist nurse if they are using the morning-after-pill containing levonorgestrel.
Epilepsy drug Trobalt (retigabine) to be discontinued
The epilepsy drug Trobalt, also known as retigabine, is to be discontinued and will no longer be available after June 2017.
Study finds 83 per cent of people with epilepsy also have headaches
A study has found that headaches cause a ‘burden’ to the quality of life of many people with epilepsy.